Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03035812Phase 4Completed
Phase 4, open-label, single-arm trial in metabolic acidosis and nephrolithiasis. Primary endpoint: Variation in the extracellular compartment at Month 3. Started Feb 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03035812.